Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nightingale Health Group’s Half-year report 1 July 2021 – 31 December 2021: Progressing faster than expected in line with strategy

Nightingale Health Plc Half-year report 1 July 2021 – 31 December 2021 (unaudited) Nightingale Health Group’s Half-year report: Progressing faster than expected in line with strategy Company Release, 24 February 2022 at 9:00 a.m. (EET) This release is a summary of Nightingale Health Plc's Half-year report from period 1 July 2021 – 31 December 2021. The full Half-year report is attached to this release. Numbers presented in brackets refer to corresponding year-on-year period unless otherwise stated. July–December 2021 key financials · Revenue was EUR 1.32 (1.01) million

Betolar and Belgian Tubobel sign a commercial agreement for a cement alternative Geoprime®

Betolar PlcCompany Announcement, inside information24 February 2022 at 8:47 A.M. EET Betolar and Belgian Tubobel sign a commercial agreement for a cement alternative Geoprime® Betolar Plc and the Belgian concrete company Tubobel Group enter into a commercial partnership to start production of low-carbon concrete products. The agreement with Betolar is valid until 2030. Tubobel, which manufactures concrete products for industry and road construction, starts manufacturing concrete pipes with Betolar's Geoprime® concept. Tubobel is the market leader in the manufacture of sewer pipes

Spinnova Plc’s Financial Statements Bulletin January–December 2021: Scaling accelerates and first technology sales materialise

SPINNOVA PLCCOMPANY RELEASE24 FEBRUARY, 2022 AT 8.45 A.M. EETSpinnova Plc’s Financial Statements Bulletin January–December 2021: Scaling accelerates and first technology sales materialise This release is a summary of Spinnova’s Financial Statements Bulletin for January to December 2021. The complete report is attached to this release and also available on the company’s website at https://spinnovagroup.com/reports/.January to December 2021 (Audited) · Revenue grew to EUR 6 063 thousand (EUR 254 thousand). · Operating loss for the period was EUR 7 172 thousand (EUR 5 473

Year-end Report January – December 2021

In 2021, we completed over 1,000 new residential units, started production on just over 1,600 units and added just over 3,600 units to our building rights portfolio, which at the end of the year amounted to just over 20,000 building rights. By the end of 2026, the number of completed properties for self-management must be over 6,000 completed units.January – December 2021 •  Net sales amounted to SEK 1,268 m (2,358). •  The operating profit was SEK 260 m (906), of which SEK 128 m (336) refers to changes in the value of investment properties. •  The net profit before tax for the

STILRIDE reaches new milestone with 100,000 sign ups for SUS1

The Swedish technology and design company STILRIDE was founded in 2020 with the ambition of taking a leading position within the rapidly growing area of electric motorcycles. Over the past two months, the company has closed an investment round, taken place in ABB's growth hub SynerLeap and attracted a lot of media attention around the world, including the UK, USA and Japan. They have also passed a milestone with over 100,000 potential customers signing up for interest in buying the SUS1.A year ago, the first concept pictures of STILRIDE's Sport Utility Scooter, SUS1, were published, and

Hunter Group ASA - Fourth quarter results 2021

Financial highlights Total revenues of USD 9.12m − Spot pool revenues of USD 1.69m − Time charter revenues of USD 7.01m Total operating expenses of USD 6.82m − Vessel opex incl. insurance of USD 2.33m − Voyage exp. and commissions of USD 0.56m − G&A expenses of 0.68m        - USD 0.29m administrative expenses        - USD 0.10m legal expenses        - USD 0.29m non-cash expenses EBITDA of USD 5.55m Net profit of USD 0.52m Average daily earnings of USD 24,100 − Avg. daily spot earnings of USD 18,400 −Avg. daily time charter earnings of USD 26,100

Interim report, May–January 2021/22

Strong demand, and supply chain challenges The demand for Elekta’s solutions continued to be strong in the third quarter, the fifth consecutive quarter with underlying order growth, resulting in Elekta’s strongest order backlog ever. However, the global supply chain challenges remained, and revenue and margins came in lower than last year. We are fully committed to returning to revenue growth and margin expansion. Gustaf SalfordPresident and CEO  Third quarter · Gross order intake amounted to SEK 4,441 M (3,954), corresponding to an 8 percent increase in constant currency.

Year-end report 2021 with interim report Q4

October - December 2021 Net sales increased by 23% Y-O-Y. Consolidated net sales ended at 57,404 (SEK 000s). EBITDA totaled -12,343 (SEK 000s). Operating profit, EBIT, was -30,786 (SEK 000s). Profit after tax was -26,887 (SEK 000s). Earnings per share was SEK -0.4. January - December 2021 Net sales increased by 25% Y-O-Y. Consolidated net sales ended at 210,826 (SEK 000s). EBITDA totaled -18,010 (SEK 000s). Operating profit, EBIT, was -69,864 (SEK 000s). Profit after tax was -87,141 (SEK 000s). Earnings per share was SEK -1.28.CEO's comments Growth journey back on track;

Notice to attend the Annual General Meeting of Skanska AB (publ)

Shareholders in Skanska AB (publ), Reg. No 556000-4615 (the “Company”), are hereby given notice of the Annual General Meeting (the “Meeting”) on Tuesday March 29, 2022.In light of the risk of the spread of Covid-19, the Board of Directors (the “Board”) has decided that the Meeting, pursuant to temporary legislation, will be conducted without physical presence, by shareholders exercising their voting rights only by postal voting.   Presentations by the Chairman of the Board, Hans Biörck, and the CEO, Anders Danielsson, where they among other things address some of the shareholders’

Nagarro swells to 15,000 colleagues worldwide

February 22, 2022: Nagarro, a global leader in digital engineering, announced that the size of the Nagarrian family had crossed the 15,000 mark. Even in a highly competitive job market, Nagarro continues to attract great engineering talent on the strength of its interesting digital projects and its unique culture. Meanwhile, Nagarro also continues to attract entrepreneurs looking for a good home for their companies and a larger playing field for themselves.   Paul Haberfellner, a Co-founder, said: "My stream of Nagarro started with only a handful of people! The other streams of

Key information relating to the cash distribution to be paid by MPC Container Ships ASA

Oslo, 24 February 2022 The distribution will be made from previously paid in share premium transferred from the Company's share premium account. Distribution amount: USD 0.11 per share Declared currency: USD. Payment to shares registered with Euronext VPS will be distributed in NOK. Last day including right: 23 March 2022 Ex-date: 24 March 2022 Record date: 25 March 2022 Payment date: 30 March 2022 (on or about) Date of board resolution: 23 February 2022 This information is published in accordance with the requirements of the Continuing Obligations. For further

MPC Container Ships ASA reports Q4 and twelve-month 2021 results

· Significantly improved operating revenues of USD 142.5 million and EBITDA of USD 162.7 million, up by 20% and 121%, respectively, compared to Q3 2021. · Quarterly dividend of USD 0.11 per share (around USD 50m) declared for Q4 2021. · Projected EBITDA backlog now in excess of USD 1.1 billion · The FY 2022 EBITDA guidance in the range of USD 450-470 million. Oslo, 24 February 2022 Q4 and twelve-month 2021 results: MPC Container Ships ASA ("MPCC" or the "Company", together with its subsidiaries the "Group") today published its unaudited financial report for the twelve-

Year-end report October - December 2021

Curasight A/S (“Curasight” or “the Company”) hereby publishes the Year-end report for the period October 1 – December 31, 2021. The Year-end report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Curasight’s CEO Ulrich Krasilnikoff comments: “As we close the books for the financial year 2021, we can look back on an eventful year in Curasight’s history. In 2021 we have accomplished several important milestones including strengthening Curasight’s IP position within diagnostics and therapy with patent approvals in both US and

First day to exercise Catena Media’s warrants (CTM TO1) for subscription of new shares during eighth exercise period

Catena Media plc (Nasdaq Stockholm: CTM)  Catena Media plc (“Catena Media” or “the company”) today announces that the eighth period to subscribe for shares in the company by exercise of warrants (ticker CTM TO1) (“the warrants”) commences today, 24 February 2022, and will run until and including 5 March 2022. During this period, each warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price of SEK 18.90. Payment of subscribed shares can be made in cash or through set-off with the full nominal amount of each hybrid capital security (ticker

Year-End Report, 2021

Calliditas became the first Company to receive accelerated approval in IgA Nephropathy.“The accelerated approval of TARPEYO was for the indication of reduction of proteinuria, which was the endpoint of Part A of the trial, in adult patients with IgA nephropathy with risk of rapid progression, which is characterized as generally UPCR ≥ 1.5 g/g.  It is well established that patients with higher levels of proteinuria have a worse outlook and prognosis as they tend to experience a more rapid decline of their kidney function, as measured by eGFR. These patients are therefore at considerable risk

BEWI – Results for the fourth quarter of 2021

BEWI, a leading provider of packaging, components, and insulation solutions, today reported its results for the fourth quarter of 2021. BEWI recorded net sales of 208.2 million euro for the fourth quarter of 2021, compared to 130.2 million euro for the same quarter last year, corresponding to an increase of 60 per cent, of which 43 percentage points are organic growth driven by higher volumes and sales prices following strong demand. Adjusted EBITDA came in at 26.4 million euro for the quarter, up from EUR 16.4 million for the fourth quarter last year. The company’s upstream segment, RAW,

Mercell reports growth and margin improvement in 2021

· Continued ARR growth to NOK 793 million, +44% year-on-year with organic growth of 18% · Revenue +83% to NOK 199 million in Q4 and +126% to NOK 706 million in 2021 · Reported EBITDA of NOK 59.7 million in Q4 and NOK 105.0 million for 2021 · Earn-out provisions reversed after downward revision of ARR in Cloudia · Adjusted EBITDA of NOK 35.5 million in Q4 and NOK 172.9 million for 2021 · Current focus on enabling continued strong and profitable growth in the existing businesses · Expecting improved EBITDA-margins in 2022, and solid free cash flow from 2022 onwards · On

Jetpak Top Holding AB (publ):Year-end Report 1 January – 31 December 2021

Fourth quarter: 1 October – 31 December 2021   · Total revenue increased by 9,6 % to 275 319 (251 276) TSEK · Organic growth amounted to 8,5 % (3,9 %) · Gross margin amounted to 31,3 % (30,9 %) · Operating profit amounted to 31 698 (27 795) TSEK · Adjusted EBITA amounted to 31 698 (28 503) TSEK · Net income amounted to 22 828 (16 652) TSEK · Basic earnings per share amounted to 1,90 (1,39) SEK · Diluted earnings per share amounted to 1,89 (1,38) SEK · Cash flow from operations amounted to 32 326 (33 082) TSEK · Cash and cash equivalents amounted to 131 666

Signs new lease agreement with Oatly founders' company Aventure in Estea's life science hub in Lund

Estea has signed a new lease agreement with the research-based food company Aventure, started by Oatly's founders, for office and laboratory premises in Estea's life science hub Forskaren in Lund. The agreement is for just under 10 years and means that Aventure doubles its area to 1,400 sqm. Estea has begun extensive adaptations that will provide Aventure with state-of-the-art offices and labs including a pilot hall for food development. - We are pleased to have the continued trust from Aventure. The Forskaren building is strategically located in the heart of Medicon Valley, one of

Lundin Gold Reports Fourth Quarter and Full Year Results

Production and Cost Performance Beats Guidance, Resulting in Free Cash Flow of $268 million Generated in 2021VANCOUVER, BC, February 23, 2022 /CNW/ Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG) ("Lundin Gold" or the "Company") today reports results for the fourth quarter and year ended December 31, 2021 (the “2021 Year”).  Lundin Gold’s excellent year is highlighted by its production of 428,514 oz of gold at an All-in Sustaining Cost (AISC)¹ of $762 per oz, beating guidance of 380,000 to 420,000 oz and AISC of $770 to $830 per oz, respectively, and resulting in free cash flow¹ of $268

Orkla Health acquires Healthspan

Orkla Health has acquired 100 per cent of the shares in Healthspan Group Limited, a leading supplier of dietary supplements in the British market.Healthspan was established in 1996 and has since built up a strong brand and a broad range of dietary supplements and skin care products. A total of 92 per cent of the company’s sales are made directly to consumers and the company has around half a million active customers.   “This acquisition is a strategically important purchase for us along several dimensions. It supports our ambitions of establishing a stronger position in consumer

Nordea Bank Abp: Repurchase of own shares on 23.02.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares23.02.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 23.02.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 400,949 10.27 4,116,598.66XHEL 401,391 10.26 4,119,074.44CEUX 370,562 10.26 3,801,377.48AQEU 17,539 10.29

Observe Medical ASA – Preliminary results of the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE. Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 9 February 2022 regarding the commencement of the subscription period in the rights issue of 25,714,286 new

Investor Report

Regulatory Announcement Royal Bank of CanadaFebruary 23, 2022 RBC Covered Bond Programme Monthly Investor Report The RBC Covered Bond Programme Monthly Investor Report has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. RBC Covered Bond Programme Monthly Investor Report dated January 31, 2022http://www.rns-pdf.londonstockexchange.com/rns/6257C_1-2022-2-23.pdf A copy of

There are no items matching the current filter
There are no more items matching the current filter
Back to top